Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: A meta-analysis of individual patient data from randomized, controlled trials

Annals of Internal Medicine

Volumn 126, Issue 10, 1997, Pages 761-767

  Gueyffier, Françis ^a   Boutitie, Florent ^a   Boissel, Jean Pierre ^a   Pocock, Stuart ^b   Coope, John ^c   Cutler, Jeffrey ^d   Ekbom, Tord ^e   Fagard, Robert ^f   Friedman, Lawrence ^d   Perry, Mitchell ^g   Prineas, Ronald ^h   Schron, Eleanor ^d  

^a Service de Pharmacologie Clinique   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Bollington Medical Centre   (United Kingdom)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e LUND UNIVERSITY   (Sweden)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g WASHINGTON UNIVERSITY   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; TREATMENT PLANNING;

EID: 0030965063     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-10-199705150-00002     Document Type: Article

References (31)

1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-38.
2. Gueyffier F, Froment A, Gouton M. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens. 1996;10:1-8.
3. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356-62.
4. MacMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis. 1986; 29(3 Suppl 1):99-118.
5. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program and Cooperative Group. JAMA. 1979;242:2562-71.
6. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985;291:97-104.
7. Amery A, Birkenhäger W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;1:1349-54.
8. The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet. 1980;1:1261-7.
9. Anastos K, Charney P, Charon RA, Cohen E, Jones CY, Marte C, et al. Hypertension in women: what is realty known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med. 1991;115:287-93.
10. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992;304:405-12.
11. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265: 3255-64.
12. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-5.
13. Kitler ME. Differences in men and women in coronary artery disease, systemic hypertension and their treatment [Editorial]. Am J Cardiol. 1992;70: 1077-80.
14. Kaplan NM. The treatment of hypertension in women. Arch Intern Med. 1995;155:563-7.
15. Gueyffier F, Boutitie F, Boissel JP, Coope J, Cutler J, Ekbom T, et al. INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. Thérapie. 1995;50:353-62.
16. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1986;293:1145-51.
17. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluation Treatment in Hypertension. Ann N Y Acad Sci. 1978;304:267-88.
18. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-71.
19. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiological Research: Principles and Quantitative Methods. Belmont, CA: Lifetime Learning Publications; 1982:403-507.
20. Boissel JP, Collet JP, Lievre M, Girard P. An effect model for the assessment of drug benefit: example of antiarrhythmic drugs in postmyocardial infarction patients. J Cardiovasc Pharmacol. 1993;22:356-63.
21. Easy MA. Reference Manual. Version 1996b. Lyon, France: Department of Clinical Pharmacology, Claude Bernard University; 1996.
22. SAS User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute: 1990.
23. Sprackling ME, Mitchell JR, Short AH, Watt G. Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa. Br Med J (Clin Res Ed). 1981;283:1151-3.
24. Perry HM Jr, Smith WM, McDonald RH, Black D, Cutler JA, Furberg CD, et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke. 1989;20:4-13.
25. Carter AB. Hypotensive therapy in stroke survivors. Lancet. 1970;1:485-9.
26. Smith WM. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res. 1977;40(5 Suppl 1):98-105.
27. Control of moderately raised blood pressure. Report of a co-operative randomised controlled trial. Br Med J. 1973;3:434-6.
28. Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group. JAMA. 1974;229:409-18.
29. WHO-ISH Joint Liaison Committee on Hypertension. Blood Pressure Lowering Treatment Trialists Collaborative Group. ISH Hypertension News. 1995;1:3.
30. Jackson R, Barham P, Bills J, Birch T, McLennan L, MacMahon S, et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ. 1993;307:107-10.
31. Ménard J, Day M, Chatellier G. Individualised drug therapy: is it time for a change from mass strategy? In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2d ed. New York: Raven Pr; 1995:3035-45.